Literature DB >> 30019515

Novel SUZ12 mutations in Weaver-like syndrome.

Eri Imagawa1, Edoarda V A Albuquerque2, Bertrand Isidor3, Satomi Mitsuhashi1, Takeshi Mizuguchi1, Satoko Miyatake1, Atsushi Takata1, Noriko Miyake1, Margaret C S Boguszewski4, César L Boguszewski5, Antonio M Lerario2,6, Mariana A Funari7, Alexander A L Jorge2, Naomichi Matsumoto1.   

Abstract

SUZ12 is a core component of polycomb repressive complex 2 (PRC2) along with EZH2 and EED. Recently, germline mutations in the SUZ12, EZH2 and EED genes have been reported in Weaver syndrome (WS) or Weaver-like syndrome, suggesting a functional link between PRC2 deficits and WS. However, only one case of a SUZ12 mutation presenting with Weaver-like syndrome has been reported. Here, we report a missense and a frameshift mutation in SUZ12 (c.1797A>C; p.Gln599His and c.844_845del; p.Ala282Glnfs*7), both of which are novel, in two individuals. Their clinical features included postnatal overgrowth, increased bifrontal diameter, large ears, round face, horizontal chin crease and skeletal anomalies, but did not fulfill the WS diagnostic criteria. These data provide strong evidence that SUZ12 mutations cause Weaver-like syndrome.
© 2018 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  SUZ12; Weaver syndrome; Weaver-like syndrome; whole exome sequencing

Mesh:

Substances:

Year:  2018        PMID: 30019515     DOI: 10.1111/cge.13415

Source DB:  PubMed          Journal:  Clin Genet        ISSN: 0009-9163            Impact factor:   4.438


  15 in total

Review 1.  From enhanceropathies to the epigenetic manifold underlying human cognition.

Authors:  Alessandro Vitriolo; Michele Gabriele; Giuseppe Testa
Journal:  Hum Mol Genet       Date:  2019-11-21       Impact factor: 6.150

Review 2.  Regulation, functions and transmission of bivalent chromatin during mammalian development.

Authors:  Trisha A Macrae; Julie Fothergill-Robinson; Miguel Ramalho-Santos
Journal:  Nat Rev Mol Cell Biol       Date:  2022-08-26       Impact factor: 113.915

Review 3.  Interplay between chromatin marks in development and disease.

Authors:  Sanne M Janssen; Matthew C Lorincz
Journal:  Nat Rev Genet       Date:  2021-10-04       Impact factor: 53.242

4.  Distinct PRC2 subunits regulate maintenance and establishment of Polycomb repression during differentiation.

Authors:  Ana Petracovici; Roberto Bonasio
Journal:  Mol Cell       Date:  2021-04-21       Impact factor: 19.328

Review 5.  Reprogramming of the epigenome in neurodevelopmental disorders.

Authors:  Khadija D Wilson; Elizabeth G Porter; Benjamin A Garcia
Journal:  Crit Rev Biochem Mol Biol       Date:  2021-10-02       Impact factor: 8.697

6.  Brain expansion promoted by polycomb-mediated anterior enhancement of a neural stem cell proliferation program.

Authors:  Shahrzad Bahrampour; Carolin Jonsson; Stefan Thor
Journal:  PLoS Biol       Date:  2019-02-26       Impact factor: 8.029

Review 7.  Tall Stature: A Challenge for Clinicians.

Authors:  Beatriz Corredor; Mehul Dattani; Chiara Gertosio; Mauro Bozzola
Journal:  Curr Pediatr Rev       Date:  2019

Review 8.  PRC2 functions in development and congenital disorders.

Authors:  Orla Deevy; Adrian P Bracken
Journal:  Development       Date:  2019-10-01       Impact factor: 6.868

9.  DNA Methylation Signature for EZH2 Functionally Classifies Sequence Variants in Three PRC2 Complex Genes.

Authors:  Sanaa Choufani; William T Gibson; Andrei L Turinsky; Brian H Y Chung; Tianren Wang; Kopal Garg; Alessandro Vitriolo; Ana S A Cohen; Sharri Cyrus; Sarah Goodman; Eric Chater-Diehl; Jack Brzezinski; Michael Brudno; Luk Ho Ming; Susan M White; Sally Ann Lynch; Carol Clericuzio; I Karen Temple; Frances Flinter; Vivienne McConnell; Tom Cushing; Lynne M Bird; Miranda Splitt; Bronwyn Kerr; Stephen W Scherer; Jerry Machado; Eri Imagawa; Nobuhiko Okamoto; Naomichi Matsumoto; Guiseppe Testa; Maria Iascone; Romano Tenconi; Oana Caluseriu; Roberto Mendoza-Londono; David Chitayat; Cheryl Cytrynbaum; Katrina Tatton-Brown; Rosanna Weksberg
Journal:  Am J Hum Genet       Date:  2020-04-02       Impact factor: 11.025

Review 10.  Overgrowth Syndromes-Evaluation, Diagnosis, and Management.

Authors:  Joshua Manor; Seema R Lalani
Journal:  Front Pediatr       Date:  2020-10-30       Impact factor: 3.418

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.